JCF 109

• CAT Number: I029758
• Molecular Formula: C24H27N3O4S
• Molecular Weight: 453.56
• Purity: 98%
• Synonyms: JCF 109; JCF109; JCF-109.
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-[[4-[(naphthalen-2-ylamino)methyl]cyclohexyl]methyl]-2-nitrobenzenesulfonamide
• InChI: InChI=1S/C24H27N3O4S/c28-27(29)23-7-3-4-8-24(23)32(30,31)26-17-19-11-9-18(10-12-19)16-25-22-14-13-20-5-1-2-6-21(20)15-22/h1-8,13-15,18-19,25-26H,9-12,16-17H2
• InChIKey: BPBPTEVVRMSHTB-UHFFFAOYSA-N
• SMILES: C1CC(CCC1CNC2=CC3=CC=CC=C3C=C2)CNS(=O)(=O)C4=CC=CC=C4[N+](=O)[O-]

JCF 109（Cat No.:I029758）is a small molecule compound studied for its potential in cancer therapy. It acts as a selective inhibitor of the protein kinase, a key enzyme involved in cell signaling pathways that regulate cell growth, survival, and proliferation. By inhibiting these kinases, JCF 109 has shown promise in blocking the growth of cancer cells, particularly in cancers with abnormal kinase activity. Preclinical studies suggest that it may be effective against various tumor types, including those resistant to other treatments. Clinical research is ongoing to evaluate its safety, efficacy, and therapeutic potential in oncology.